IsoRay, Inc. (ISR)
--USD
--
-- (--)
$1.03
--
--
--
--
340,134
$2.06
$0.12
About
Overall
| Beta: | 2.38 |
| Market Cap (Mil.): | $23.63 |
| Shares Outstanding (Mil.): | 22.94 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| ISR | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 4.05 | 3.76 |
| EPS (TTM): | 35.37 | -- | -- |
| ROI: | -42.58 | 2.37 | 2.30 |
| ROE: | -45.47 | 3.77 | 2.82 |
Isoray Q1 results
ISORAY INC : * First quarter per share loss $0.09 * First quarter sales $1.86 million * Reuters Estimates first quarter earnings per share view $-0.09, revenue view $1.88 million
IBt '07 net not to improve given U.S. closure costs
BRUSSELS, Sept 28 (Reuters) - Belgian radiotherapy implant maker International Brachytherapy said on Friday that one-off costs of ending its loss-making U.S. presence meant it would not meet its target of improving its net result in 2007.
RPT-IBt ends U.S. activity, plans alliance with IsoRay
BRUSSELS, Sept 27 (Reuters) - Belgian radiotherapy implant maker International Brachytherapy said on Thursday it had decided to end its loss-making activities in the U.S and eyed a strategic alliance with U.S. counterpart IsoRay .
IBt ends U.S. activity, plans alliance with IsoRay
BRUSSELS, Sept 27 (Reuters) - Belgian radiotherapy implant maker International Brachytherapy said on Thursday it had decided to end its loss-making activities in the U.S and eyed a strategic alliance with U.S. counterpart IsoRay .
Competitors
| Price | Change | |
|---|---|---|
| Theragenics Corporation (TGX.N) | $1.28 | +0.01 |
| North American Scientific, Inc. (NASMQ.PK) | $0.00 | 0.00 |





Earnings vs
Estimates